DMVeille DM

Field safety notices: THERADIAG

Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.

3 authority publications by 2 authorities, from 18 Aug 2021 to 24 May 2023.

Latest notice: 24 May 2023, ANSM, Réactifs Fidis Vasculitis, Fidis Celiac IgA & Fidis Celiac IgG

Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by THERADIAG or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.

2 distinct corrective actions.

  1. Réactifs Fidis Vasculitis, Fidis Celiac IgA & Fidis Celiac IgG

    Source : ANSM, informations de sécurité · collected 16 Nov 2026

Corrective action: 2 publications by AEMPS, ANSM, from 18 Aug 2021 to 7 Oct 2021

  1. Kit i-Tracker infliximab, referencia CTI 002-100

    Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026

  2. Réactif I-Tracker Infliximab

    Source : ANSM, informations de sécurité · collected 16 Nov 2026

The authorities that published these notices